CTRI/2023/03/050258
Recruiting
未知
Technical Validation of Liquid biopsy for solid tumors
Cancer Research and Statistic Foundation CRSF0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
- Sponsor
- Cancer Research and Statistic Foundation CRSF
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All cancer patients registered in Homi Bhabha Cancer Hospital \& Research Center, Muzaffarpur
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIson-small cell Lung CancerJPRN-UMIN000023248PHRF122
Active, not recruiting
Phase 1
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code: 10025055Term: Lung cancer non-small cell stage IV Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2024-511317-38-00Fundacion GECP33
Active, not recruiting
Phase 1
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2019-002369-36-ESFundación GECP30
Not yet recruiting
Not Applicable
Exploratory analysis of liquid biopsy for the predictive factors associated with outcome of PD-1 Pathway Blockade in Multicenter Studynon-small cell lung cancerJPRN-jRCT1032220559Ohe Yuichiro100
Not yet recruiting
Not Applicable
Quality Assessment of New Liquid Biopsy TechniquesCancerneoplasm10027655NL-OMON49338Erasmus MC, Universitair Medisch Centrum Rotterdam30